TATA Health International : MONTHLY UPDATE ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE AND CLOSURE OF OFFER PERIOD

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

TATA Health International Holdings Limited

TATA 健 康 國 際 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1255)

MONTHLY UPDATE ANNOUNCEMENT

PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE

AND

CLOSURE OF OFFER PERIOD

This announcement is made by TATA Health International Holdings Limited (the ''Company'') pursuant to Rule 3.7 of The Code on Takeovers and Mergers and Share Buy-backs (the ''Takeovers Code'').

Reference is made to the announcements of the Company dated 12 May 2020, 12 June 2020, 13 July 2020, 13 August 2020, 11 September 2020, 12 October 2020, 12 November 2020, 11 December 2020, 12 January 2021, 11 February 2021 and 12 March 2021 (the ''Announcements'') in relation to, among others, the possible transaction in which the Receivers may look for potential purchaser(s) for the Charged Shares (the ''Possible Transaction''), respectively. Unless otherwise defined, capitalised terms used herein have the same meanings as those defined in the Announcements.

MONTHLY UPDATE

The Company wishes to update the shareholders and potential investors of the Company that, upon enquiry undertaken by the Company, the Possible Transaction is still currently suspended (i.e. the Receivers will not look for potential purchaser(s) for the Charged Shares) until further notice. The Receivers have confirmed that, as at the date of this announcement, they are not in discussion with any potential purchaser(s) in respect of the disposal of the Charged Shares which may have implications under Rule 26.1 of the Takeovers Code.

- 1 -

CLOSURE OF OFFER PERIOD

As the Receivers are not currently looking for potential purchasers for the Charged Shares, for the purpose of the Takeovers Code, the offer period in respect of the Possible Transaction is closed on the date of this announcement, being 12 April 2021.

Shareholders and potential investors of the Company should exercise caution when dealing in the securities of the Company, and if they are in any doubt about their position, they should consult their professional adviser(s).

By order of the Board

TATA Health International Holdings Limited

Yang Jun

Chairman

Hong Kong, 12 April 2021

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. Yang Jun and Mr. Lai Wenjing; five non-executive Directors, namely, Mr. Lin Zheming, Mr. Law Fei Shing, Mr. Lin Jun, Mr. Chu Chun Ho, Dominic and Mr. Chen Anhua and four independent non-executive Directors, namely, Mr. Xie Rongxing, Mr. Lum Pak Sum, Prof. Yan Haifeng and Ms. Tan Yuying.

The Directors jointly and severally accept full responsibility for the accuracy of information contained in this announcement and confirm, having made all reasonable inquiries, that to the best of their knowledge, opinions expressed in this announcement have been arrived at after due and careful consideration and there are no other facts not contained in this announcement, the omission of which would make any statement in this announcement misleading.

- 2 -